Effect of increasing the surface sampled by imprint cytology on the intraoperative assessment of axillary sentinel lymph nodes in breast cancer patients

American Surgeon

Volumn 69, Issue 5, 2003, Pages 419-423

  Cserni, G ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; DISULFINE BLUE; FUCHSINE; MACROSALB TC 99M; RADIOPHARMACEUTICAL AGENT;

ARTICLE; AXILLA; BREAST TUMOR; CANCER STAGING; EVALUATION; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE; METHODOLOGY; PATHOLOGY; PREDICTION AND FORECASTING; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODES; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; ROSANILINE DYES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 0038010545     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Valagussa P, Bonadonna G, Veronesi U. Patterns of relapse and survival following radical mastectomy. Cancer 1978;41:1170-1178
2. Fisher B, Bauer M, Wickerham DL, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: An NSABP update. Cancer 1983;52:1551-1557
3. Henson DE, Fielding P, Grignon DJ, et al. College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors: Summary. Arch Pathol Lab Med 1995;119:1109-1112 (Pubitemid 26068762)
4. Rahusen FD, Pijpers R, van Diest PJ, et al. The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer. Surgery 2000;128:6-12. (Pubitemid 30456888)
5. Miltenburg DM, Miller C, Karamlou TB, Brunicardi FC. Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 1999;84:138-142 (Pubitemid 29389989)
6. Cserni G. The potential value of intraoperative imprint cytology of axillary sentinel lymph nodes in breast cancer patients. Am Surg 2001;67:86-91. (Pubitemid 33638501)
7. Cserni G, Boross G, Baltás B. Value of axillary sentinel nodal status in breast cancer. World J Surg 2000;24:341-344 (Pubitemid 30117764)
8. Cserni G, Rajtár M, Boross G, Sinkó M, Svébis M, Baltás B. Comparison of vital dye-guided lymphatic mapping and dye plus gamma probe-guided sentinel node biopsy in breast cancer. World J Surg 2002;26:592-597 (Pubitemid 36920373)
9. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumors, 6th Ed. New York: Wiley-Liss, 2002.
10. Giuliano AE, Jones RC, Brennan M, Statman R, Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-2350
11. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: A multicenter validation study. N Engl J Med 1998;339:941-946 (Pubitemid 28455095)
12. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series. J Natl Cancer Inst 1999;91:368-373 (Pubitemid 29102337)
13. Bass SS, Cox CE, Ku NN, et al. The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg 1999;189:183-189
14. Derossis AM, Fey J, Yeung H, et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg 2001;193:473-478 (Pubitemid 33043448)
15. Giuliano AE, Dale PS, Turner RR. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;180:700-704
16. Cserni G. Axillary staging of breast cancer and the sentinel node. J Clin Pathol 2000;53:733-741 (Pubitemid 30766053)
17. Ku NNK. Pathologic examination of sentinel lymph nodes in breast cancer. Surg Oncol Clin N Am 1999;8:469-479 (Pubitemid 29321216)
18. Ku N, Cox C, Reintgen D, et al. Role of intraoperative imprint cytology on sentinel nodes in breast cancer. Eur J Nucl Med 1999;26(Suppl):S56.
19. Chu KU, Turner RR, Hansen NM, et al. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999;229:536-541
20. Reynolds C, Mick R, Donohue JH, et al. Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 1999;17:1720-1726
21. Liang WC, Sickle-Santanello BJ, Nims TA. Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node? Am J Surg 2001;182:365-368
22. Weiser MR, Montgomery LL, Tan LK, et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 2001;8:145-149
23. Cserni G. Sentinel lymph node biopsy-based prediction of further breast cancer metastases in the axilla. Eur J Surg Oncol 2001;27:532-538 (Pubitemid 32842722)
24. Ishikawa H, Sato K, Mochizuki H. Optimal sentinel node examination and a new strategy for axillary control in breast cancer. Breast J 2002;8:10-14 (Pubitemid 34118478)
25. Teng S, Dupont E, McCann C, et al. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer? Am Surg 2000;66:574-578
26. Viale G, Maiorano E, Mazzarol G, et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001;92:1378-1384 (Pubitemid 32947820)
27. Chua B, Ung O, Taylor R, et al. Treatment implications of a positive sentinel lymph node biopsy for patients with early-stage breast carcinoma. Cancer 2001;92:1769-1774 (Pubitemid 32952494)
28. Rahusen FD, Torrenga H, van Diest PJ, et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg 2001;136:1059-1063 (Pubitemid 32982998)
29. Rubio IT, Korourian S, Cowan C, et al. Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol 1998;5:689-694 (Pubitemid 28565719)
30. Ratanawichitrasin A, Biscotti CV, Levy L, Crowe JP. Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer. Br J Surg 1999;86:1346-1349 (Pubitemid 29481549)
31. Diest PJ van, Torrenga H, Borgstein PJ, et al. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology 1999;35:14-18 (Pubitemid 29325292)
32. Noguchi M, Bando E, Tsugawa K. et al. Staging efficacy of breast cancer with sentinel lymphadenectomy. Breast Cancer Res Treat 1999;57:221-229 (Pubitemid 29531468)
33. Keshtgar MRS, Kocjan G, Lakhani SR, Ell PJ. Imprint cytology in sentinel node biopsy in breast cancer: Is it reliable? Abstract. Eur J Nucl Med 1999;26(Suppl):S56.
34. Kane JM 3rd, Edge SB, Winston JS, et al. Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection. Ann Surg Oncol 2001;8:361-367
35. Henry-Tillman RS, Korourian S, Rubio IT, et al. Intraoperative touch preparation for sentinel lymph node biopsy: A 4-year experience. Ann Surg Oncol 2002;9:333-339 (Pubitemid 34496720)
36. Reuhl T, Kaisers H, Markwardt J, et al. Axillaausraumung bei klinisch nodal-negativen Mammakarzinom. Kann die Indikation durch "sentinel node" - Nachweis individualisiert werden? Dtsch Med Wochenschr 1998;123:583-587
37. Koller M, Barsuk D, Zippel D, et al. Sentinel lymph node involvement - a predictor for axillary node status with breast cancer: Has the time come? Eur J Surg Oncol 1998;24:166-168
38. Cavanese G, Gipponi M, Catturich A, et al. Sentinel lymph node mapping opens a new perspective in the surgical management of early-stage breast cancer: A combined approach with vital blue dye lymphatic mapping and radioguided surgery. Semin Surg Oncol 1998;15:272-277 (Pubitemid 28512008)
39. Schneebaum S, Stadler J, Cohen M, et al. Gamma probe-guided sentinel node biopsy: Optimal timing for injection. Eur J Surg Oncol 1998;24:515-519 (Pubitemid 28566896)
40. Mayzler O, Goldstein J, Koretz M. Is frozen section examination of the sentinel lymph node a reliable predictor of histologic status? Abstract. Eur J Nucl Med 1999;26(Suppl):S56.
41. Chao C, Wong SL, Ackermann D, et al. Utility of intraoperative frozen section analysis of sentinel lymph nodes in breast cancer. Am J Surg 2001;182:609-615 (Pubitemid 34142680)
42. Gulec SA, Su J, O'Leary JP, Stolier A. Clinical utility of frozen section in sentinel node biopsy in breast cancer. Am Surg 2001;67:529-532 (Pubitemid 33738844)
43. Turner RR, Giuliano AE. Intraoperative pathologic examination of the sentinel lymph node. Ann Surg Oncol 1998;5:670-672 (Pubitemid 28565716)